Lipid composition has significant effect on targeted drug delivery properties of NGR-modified liposomes

References

• Agrawal SS, Saraswati S, Mathur R, Pandey M. (2011). Cytotoxic and antitumor effects of brucine on Enrlich ascites tumor and human cancer cell line. Life Sci 89:147–58
   PubMed Web of Science ®Google Scholar
• Alavizadeh SH, Badiee A, Golmohammadzadeh S, Jaafari MR. (2014). The influence of phospholipid on the physicochemical properties and anti-tumor efficacy of liposomes encapsulating cisplatin in mice bearing C26 colon carcinoma. Int J Pharm 473:326–33
   PubMed Web of Science ®Google Scholar
• Chen J, He CQ, Lin AH, et al. (2014). Brucine-loaded liposomes composed of HSPC and DPPC at different ratios: in vitro and in vivo evaluation. Drug Dev Ind Pharm 40:244–51
   PubMed Web of Science ®Google Scholar
• Chen J, Lin AH, Chen ZP, et al. (2010). Ammonium sulfate gradient loading of brucine into liposomes: effect of phospholipid composition on entrapment efficiency and physicochemical properties in vitro. Drug Dev Ind Pharm 36:245–53
   PubMed Web of Science ®Google Scholar
• Chen J, Ping QN, Guo JX, et al. (2006). Effect of phospholipid composition on characterization of liposomes containing 9-nitrocamptothecin. Drug Dev Ind Pharm 32:719–26
   PubMed Web of Science ®Google Scholar
• Chen J, Yan GJ, Hu RR, et al. (2012). Improved pharmacokinetics and reduced toxicity of brucine after encapsulation into stealth liposomes: role of phosphatidylcholine. Int J Nanomed 7:3567–77
   PubMed Web of Science ®Google Scholar
• Corti A, Ponzoni M. (2004). Tumor vascular targeting with tumor necrosis factor alpha and chemotherapeutic drugs. Ann NY Acad Sci 1028:104–12
   PubMed Web of Science ®Google Scholar
• Deng XK, Yin FZ, Lu XY, et al. (2006). The apoptotic effect of brucine from the seed of Strychnos nux-vomica on human hepatoma cells is mediated via Bcl-2 and Ca2+ involved mitochondrial pathway. Toxicol Sci 91:59–69
   PubMed Web of Science ®Google Scholar
• Dini L, Falasca L, Ruzzittu MT, et al. (1998). Interaction between isolated and purified liver cells and small unilamellar liposomes. Liver 18:229–38
   PubMedGoogle Scholar
• Dunne M, Zheng J, Rosenblat J, et al. (2011). APN/CD13-targeting as a strategy to alter the tumor accumulation of liposomes. J Control Release 154:298–305
   PubMed Web of Science ®Google Scholar
• Eley JG, Pujari VD, McLane J. (2004). Poly(lactide-co-glycolide) nanoparticles containing coumarin-6 for suppository delivery: in vitro release profile and in vivo tissue distribution. Drug Deliv 11:255–61
   PubMed Web of Science ®Google Scholar
• Fukasawa K, Fujii H, Saitoh Y, et al. (2006). Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesis. Cancer Lett 243:135–43
   PubMed Web of Science ®Google Scholar
• Garde SV, Forté AJ, Ge M, et al. (2007). Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects. Anticancer Drugs 18:1189–200
   PubMed Web of Science ®Google Scholar
• Kan P, Tsao C, Wang A, et al. (2011). A liposomal formulation able to incorporate a high content of paclitaxel and exert promising anticancer effect. J Drug Deliv 2011:629234
   PubMedGoogle Scholar
• Li C, Cui J, Wang C, et al. (2008). Lipid composition and grafted PEG affect in vivo activity of liposomal mitoxantrone. Int J Pharm 362:60–6
   PubMed Web of Science ®Google Scholar
• Li P, Zhang M, Ma W, et al. (2012). Effects of brucine on vascular endothelia growth factor expression and microvessel density in a nude mouse model of bone metastasis due to breast cancer. Chinese J Integr Med 18:605–9
   PubMed Web of Science ®Google Scholar
• Lindner LH, Hossann M. (2010). Factors affecting drug release from liposomes. Curr Opin Drug Disc 13:111–23
   PubMed Web of Science ®Google Scholar
• Luo LM, Huang Y, Zhao BX, et al. (2013). Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel. Biomaterials 34:1102–14
   PubMed Web of Science ®Google Scholar
• Negussie AH, Miller JL, Reddy G, et al. (2010). Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome. J Control Release 143:265–73
   PubMed Web of Science ®Google Scholar
• Pastorino F, Brignole C, Marimpletri D, et al. (2003). Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy. Cancer Res 63:7400–9
   PubMed Web of Science ®Google Scholar
• Senior J. (1982). Is half-life of circulating liposomes determined by changes in their permeability? FEBS Lett 145:109–14
   PubMed Web of Science ®Google Scholar
• Takara K, Hatakeyama H, Kibria G, et al. (2012). Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy. J Control Release 162:225–32
   PubMed Web of Science ®Google Scholar
• Xie X, Yang Y, Yang Y, et al. (2015). A photo-responsive peptide- and asparagine-glycine-arginine (NGR) peptide-mediated liposomal delivery system. Drug Deliv [Epub ahead of print]. doi: 10.3109/10717544.2015.1008707
   Google Scholar
• Yin W, Deng XK, Yin FZ, et al. (2007). The cytotoxicity induced by brucine from the seed of Strychnos nux-vomica proceeds via apoptosis and is mediated by cyclooxygenase 2 and caspase 3 in SMMC 7721 cells. Food Chem Toxicol 45:1700–8
   PubMed Web of Science ®Google Scholar